Parent-Adolescent Interactions and Adolescent Development (PAIT)

This study is currently recruiting participants.
Verified January 2014 by George Mason University
Sponsor:
Collaborators:
ABMRF/The Foundation for Alcohol Research
Information provided by (Responsible Party):
Tara M. Chaplin, Ph.D., George Mason University
ClinicalTrials.gov Identifier:
NCT01572441
First received: April 3, 2012
Last updated: January 7, 2014
Last verified: January 2014
  Purpose

The purpose of this study is to observe parent-adolescent interactions and to examine the parenting behaviors and adolescent emotional and physiological responses that are associated with youth's substance use.


Condition
Substance Abuse

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Responses During Parent-child Interactions and Alcohol Use Behavior in Adolescents.

Resource links provided by NLM:


Further study details as provided by George Mason University:

Primary Outcome Measures:
  • Substance Use [ Time Frame: Baseline ] [ Designated as safety issue: No ]
    Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.

  • Substance Use [ Time Frame: 6 month follow-up ] [ Designated as safety issue: No ]
    Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.

  • Substance Use [ Time Frame: 1 year follow-up ] [ Designated as safety issue: No ]
    Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.

  • Substance Use [ Time Frame: 2 year follow-up ] [ Designated as safety issue: No ]
    Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.

  • Substance Use [ Time Frame: 3 year follow-up ] [ Designated as safety issue: No ]
    Measured by a combination of self-report on the Youth Risk Behavior Survey and the Teen Addiction Severity Index and urine toxicology and alcohol breathalyzer results.


Biospecimen Retention:   Samples With DNA

Retain saliva sample.


Estimated Enrollment: 400
Study Start Date: September 2009
Estimated Study Completion Date: July 2017
Estimated Primary Completion Date: July 2017 (Final data collection date for primary outcome measure)
Groups/Cohorts
10-17 year olds
No intervention administered. This is a longitudinal observational study including observation of behaviors and physiological responses.

  Eligibility

Ages Eligible for Study:   10 Years to 17 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

10-17 year olds and their primary caregivers.

Criteria

Inclusion Criteria:

  • Adolescent between ages 10-17 years

Exclusion Criteria:

  • For adolescent, Intelligence Quotient (IQ) < 70 on standardized test, for parent, evidence of inability to read or write.
  • Evidence of a psychotic disorder for parent or adolescent
  • Diagnosis of autism or pervasive developmental disorder for adolescent, as determined by parent report in the screening.
  • For adolescent, current need for acute treatment of a psychiatric disorder, as determined by parent report in the study screening.
  • For adolescent and parent, inadequate English proficiency to comprehend task instructions
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01572441

Locations
United States, Connecticut
Yale Stress Center Recruiting
New Haven, Connecticut, United States, 06519
Contact: Tara Chaplin, Ph.D.    203-737-5201    tara.chaplin@yale.edu   
Principal Investigator: Tara Chaplin, Ph.D.         
Sponsors and Collaborators
George Mason University
ABMRF/The Foundation for Alcohol Research
Investigators
Principal Investigator: Tara Chaplin, Ph.D. Yale University
  More Information

Publications:
Responsible Party: Tara M. Chaplin, Ph.D., Assistant Professor of Psychology, George Mason University
ClinicalTrials.gov Identifier: NCT01572441     History of Changes
Other Study ID Numbers: 0909005677, K01DA024759, R10629
Study First Received: April 3, 2012
Last Updated: January 7, 2014
Health Authority: United States: Institutional Review Board
United States: Federal Government

Additional relevant MeSH terms:
Substance-Related Disorders
Mental Disorders

ClinicalTrials.gov processed this record on April 22, 2014